Clinical Guides
Infective Endocarditis
A clinically focused India-contextualised guide to suspected infective endocarditis, covering cultures, imaging, contemporary diagnostic criteria, antimicrobial stewardship, prophylaxis, complications and surgery while keeping patient-specific treatment within an Endocarditis Team.
MedNext Academy | 14 min read
Infective Endocarditis
A clinically focused India-contextualised guide to suspected infective endocarditis, covering cultures, imaging, contemporary diagnostic criteria, antimicrobial stewardship, prophylaxis, complications and surgery while keeping patient-specific treatment within an Endocarditis Team.
Summary
Infective endocarditis is infection of the endocardial surface, usually involving a native or prosthetic valve but also affecting repaired valves, intracardiac devices or congenital lesions. It is clinically heterogeneous: fever and a new regurgitant murmur may be obvious, yet older adults, immunocompromised people and patients pretreated with antibiotics can present with stroke, heart failure, renal injury or persistent inflammation without a classic picture. Rheumatic valve disease remains a relevant substrate in India alongside prosthetic valves, haemodialysis access, cardiac devices, healthcare exposure, congenital disease and injection drug use.
Diagnosis is a synthesis, not a single test. Obtain multiple properly filled peripheral blood-culture sets before antimicrobials when the patient is stable, perform transthoracic echocardiography promptly and escalate to transoesophageal or additional imaging when suspicion remains high. The 2023 Duke-ISCVID and 2023 ESC criteria organize microbiology, imaging, surgical and clinical findings, but criteria support rather than replace judgement. Early collaboration among cardiology, infectious diseases, microbiology, imaging and cardiac surgery improves coherent decisions.
Antimicrobial therapy is prolonged, intravenous for much of the acute course, organism- and susceptibility-directed, and adjusted for valve type, complications, renal function, allergy and prior exposure. Empirical therapy should follow cultures and local ecology unless instability makes delay unsafe. Surgery is considered principally for heart failure, uncontrolled infection and prevention of embolic catastrophe in defined settings. Antibiotic prophylaxis is restricted to highest-risk cardiac groups and relevant procedures; oral hygiene and prompt treatment of infection are broader preventive measures. This educational draft is quarantined, reviewed and has been reviewed by the MedNext Clinical Team.
How Common Is It?
Infective endocarditis is uncommon relative to pneumonia or urinary infection, but its mortality, neurological injury, valve destruction and need for surgery make missed or delayed diagnosis consequential. Incidence estimates vary because case definitions, blood-culture access, echocardiography, referral pathways and populations differ. International cohorts increasingly include older people with degenerative valves, prostheses and devices. Indian tertiary centres additionally see rheumatic disease, late referral, prior community antibiotic exposure and uneven access to cardiac surgery. A hospital series cannot be converted into a national community rate because referral centres selectively receive severe and complex cases.
The microbiological distribution also depends on exposure. Staphylococci are prominent with healthcare contact, vascular access and injection drug use; oral streptococci, Streptococcus gallolyticus, enterococci, HACEK organisms, fungi and fastidious organisms occur in different contexts. Prosthetic-valve and device infection has timing- and setting-specific ecology. Culture-negative disease may reflect antibiotics taken before cultures, inadequate sampling, intracellular or difficult-to-grow organisms, fungi or a non-infective mimic. The proportion labelled culture negative therefore partly measures healthcare process.
Local surveillance should record native versus prosthetic or device infection, acquisition setting, prior antimicrobials, organism, susceptibility, time to cultures and echocardiography, surgical indication, transfer delay and outcome. The ICMR antimicrobial guideline itself cautions that resistance data from selected tertiary hospitals do not represent every community or institution. This guide accordingly avoids an unsupported current all-India incidence or universal pathogen ranking and treats local microbiology and referral capacity as essential inputs.
Risk Factors
Cardiac substrates include previous infective endocarditis, prosthetic valves or prosthetic repair material, selected congenital heart disease, rheumatic or degenerative valve damage and intracardiac devices. Not every murmur carries equal risk. The highest risk of an adverse outcome, which informs procedural prophylaxis, is narrower than the broad population in whom endocarditis can occur. A repaired native valve without prosthetic material and isolated rheumatic disease should not automatically be placed into a prophylaxis category without checking the applicable guideline.
Bacteraemia risk rises with poor oral health, invasive dental disease, infected skin or soft tissue, injection drug use, haemodialysis, central venous access and healthcare-associated procedures. Recent hospitalisation, surgery, device implantation and prolonged intravenous therapy change likely organisms and resistance. Immunosuppression, diabetes, chronic kidney disease, older age and frailty can blunt presentation and worsen tolerance. In India, rheumatic valve disease, interrupted dental care, informal antibiotic access and transfer between facilities may coexist, but these must be documented rather than presumed.
Previous antibiotics are a diagnostic risk because they reduce culture yield and can convert a treatable organism into an apparently culture-negative problem. Ask exactly what was taken, when, for how long and whether any cultures were obtained first. Prosthetic-valve infection, Staphylococcus aureus bacteraemia, persistent bacteraemia, fungal infection and peri-annular extension carry particular complication risk. Prevention includes oral hygiene, dental follow-up, aseptic vascular-access care, prompt source control and harm-reduction support. Routine antibiotics for every invasive procedure are not prevention: unnecessary exposure causes allergy, toxicity, Clostridioides difficile infection and antimicrobial resistance.
Diagnosis
History
Ask about fever, rigors, night sweats, weight loss, malaise, dyspnoea, orthopnoea, chest or back pain, focal neurological symptoms, limb pain, abdominal pain and haematuria. Establish valve disease, rheumatic fever, prosthesis or repair material, previous endocarditis, congenital disease, cardiac device, haemodialysis, vascular access, recent dental or surgical procedures, skin infection and injection exposure. Record every antimicrobial dose before presentation. Acute collapse suggests severe regurgitation, sepsis, embolism or mechanical complication; weeks of fatigue may still represent destructive disease.
Examination
Assess sepsis physiology, perfusion, oxygenation, heart failure and neurological status before searching for peripheral stigmata. Compare murmurs with previous records; a new regurgitant murmur supports concern, but no murmur excludes neither early nor right-sided disease. Examine prosthetic sounds, device pockets, injection sites, skin, nails, eyes, joints, spine, spleen and retina when safe. Classic Janeway lesions, Osler nodes, splinter haemorrhages and Roth spots are educationally memorable but variably present and not individually diagnostic.
Investigations
Draw at least three appropriately collected peripheral blood-culture sets before antibiotics in a stable patient, using correct volume and labelling; do not wait for fever spikes. Severe sepsis or shock requires cultures immediately followed by therapy. Order transthoracic echocardiography promptly. Use transoesophageal echocardiography for prosthetic or device infection, inadequate or negative transthoracic imaging with persistent suspicion, suspected complications or surgical planning. Repeat imaging when early studies are nondiagnostic and suspicion remains. Full blood count, renal and liver profiles, inflammatory markers, urinalysis and ECG establish complications and treatment safety. Culture-negative pathways use microbiology advice, targeted serology or molecular testing and selected CT, PET/CT or MRI rather than an indiscriminate panel.
Differential Diagnosis
Non-infective thrombotic endocarditis, Libman-Sacks lesions, marantic vegetations, Lambl excrescences, degenerative strands, thrombus and cardiac tumours can mimic a vegetation. Malignancy, systemic lupus erythematosus and antiphospholipid syndrome may produce emboli and sterile valve lesions. Echocardiographic appearance alone cannot reliably identify organism or prove infection; clinical context, serial imaging, microbiology and sometimes tissue are required. An incidental valve mass should not trigger weeks of antimicrobial therapy without a coherent diagnosis.
Fever with a murmur also occurs in pneumonia, urinary infection, tuberculosis, viral illness, malaria, enteric fever, deep abscess, osteomyelitis and line infection without valve involvement. Persistent Staphylococcus aureus bacteraemia requires active evaluation for endocarditis and metastatic foci, but another source does not automatically exclude valve seeding. Stroke with fever may represent endocarditis, meningitis, vasculitis or an unrelated infection accompanying atherosclerotic stroke. Glomerulonephritis, vasculitis and connective-tissue disease can reproduce renal, skin and inflammatory findings.
Acute pulmonary oedema and shock demand differentiation from myocardial infarction with papillary-muscle rupture, acute aortic regurgitation, ventricular septal rupture, myocarditis, pulmonary embolism and primary sepsis-induced cardiomyopathy. Culture-negative suspicion should first revisit antibiotic exposure, collection quality and incubation before invoking rare organisms. Coxiella burnetii, Bartonella species, Brucella, fungi and other fastidious pathogens are selected by epidemiology, animal exposure, travel, immune status and valve type. Diagnostic criteria classify probability, but a rejected research classification does not excuse ignoring a dangerous alternative or repeating appropriately timed investigations.
Management
Stabilize airway, breathing, circulation and organ perfusion while obtaining cultures and urgent echocardiography. Notify microbiology before specimens from a pretreated or prosthetic-valve case are discarded under routine protocols. An Endocarditis Team should coordinate antimicrobial, imaging, embolic, neurological and surgical decisions. Remove or control an infected intravascular source when indicated, but do not manipulate a cardiac device or prosthesis without specialist planning. Daily review should track fever, cultures, renal function, conduction, heart failure, emboli, drug toxicity and the evolving surgical indication.
Begin empirical intravenous antimicrobial therapy immediately after cultures in shock, severe sepsis or rapidly destructive disease. In a stable patient, cultures should precede therapy and specialist selection should account for native versus prosthetic valve, community versus healthcare acquisition, previous drugs, allergy and local susceptibility. Narrow promptly when the organism and minimum inhibitory concentrations are known. Duration is counted according to the verified regimen and clinical context, not copied from a generic discharge summary. Persistent positivity requires investigation of uncontrolled infection, abscess, wrong drug exposure, resistant pathogen, infected hardware or metastatic focus.
Surgery is not a last resort after antimicrobial failure. Major indications cluster around heart failure from severe valve dysfunction, uncontrolled infection such as abscess or persistent microorganisms, and prevention of embolism in selected vegetation and risk settings. Timing after neurological events is individualized by haemorrhage, infarct severity and haemodynamic urgency. Prosthetic-valve and device infection often requires early surgical or extraction expertise. Stable selected patients may complete therapy through structured outpatient or oral pathways under guideline-defined criteria, but this needs clinical stability, susceptible organisms, adherence, monitoring, rapid re-entry and reliable follow-up; it is not a cost-driven early discharge shortcut.
Prescribing Information
Endocarditis regimens are organism-, valve-, susceptibility- and phase-specific and should be verified with infectious-diseases, cardiology, microbiology and pharmacy input. Before prescribing, document blood-culture timing, species identification, minimum inhibitory concentrations, native or prosthetic material, allergy phenotype, weight, renal and hepatic function, pregnancy, interactions and metastatic infection. Record exact drug, route, dose, interval, infusion method, planned duration and monitoring. Therapeutic drug monitoring is required for selected agents; aminoglycosides and glycopeptides can cause substantial renal, auditory or other toxicity.
ICMR guidance provides an India-oriented empirical framework but explicitly states that susceptibility data from selected tertiary hospitals do not represent every institution. Its 2019 document must not be mistaken for a current local antibiogram or copied without checking newer resistance, formulary and dosing standards. Empirical coverage differs for community native-valve, healthcare-associated, early or late prosthetic-valve and device infection. Previous antibiotics and colonisation history matter. Once cultures identify a pathogen, de-escalate to the narrowest effective evidence-based regimen and pursue source control. Do not add synergistic agents by habit when benefit is uncertain and toxicity is substantial.
In a stable patient, avoid administering an unrecorded antibiotic before adequate cultures. In shock, obtain cultures immediately but never postpone lifesaving treatment for a prolonged sampling ritual. A reported penicillin allergy requires careful history and, when feasible, evaluation because an inaccurate label can force broader or more toxic therapy. Anticoagulation is not initiated to prevent septic emboli; existing antithrombotic therapy requires individualized review, especially with stroke, haemorrhage, prosthetic valves or planned surgery. At discharge, define line care, laboratory surveillance, missed-dose action, adverse-effect warnings, responsible prescriber and an end date.
When to Refer
Suspected infective endocarditis warrants prompt hospital evaluation when there is persistent fever with a prosthetic valve, prior endocarditis, cardiac device, known valve disease, positive blood cultures with a typical organism, new regurgitation, embolic signs or unexplained systemic inflammation. Referral information should include all blood-culture results and collection times, antibiotics with exact timing, haemodynamics, neurological findings, renal function, valve or device history and echocardiographic images. Do not delay transfer while repeating low-yield empirical outpatient courses.
Early discussion with a centre that has cardiology, infectious diseases, microbiology, advanced imaging and cardiac surgery is appropriate for prosthetic-valve or device infection, severe valve dysfunction, heart failure, abscess, new conduction abnormality, persistent bacteraemia, fungal or difficult-to-treat infection, recurrent emboli, large mobile vegetation or diagnostic uncertainty. The transferring team should continue sepsis care and organism-directed therapy while confirming bed, transport and surgical capability. A vague instruction to seek a specialist without a receiving service is unsafe.
Neurology or neurosurgery input is required for stroke, intracranial haemorrhage, mycotic aneurysm concern, meningism or focal deficit. Spine, joint, renal, ophthalmic and other teams address metastatic foci when indicated. In India, access may span district hospitals, medical colleges and regional cardiac centres; transoesophageal echocardiography, PET/CT, valve culture molecular testing and emergency surgery are not uniformly available. Escalate based on clinical risk rather than waiting for every advanced test locally. After treatment, cardiology and infectious-diseases follow-up should monitor relapse, valve function, heart failure, dental health and prevention education.
Red Flags
Pulmonary oedema, hypotension, escalating oxygen need, cool peripheries or altered mental status may reflect acute severe regurgitation, valve obstruction, sepsis or peri-annular destruction. These findings demand emergency resuscitation, echocardiography and surgical discussion. A new atrioventricular block or other conduction change suggests extension near the conduction system and should not be treated as an isolated ECG abnormality. Persistent positive cultures despite appropriate therapy raise uncontrolled infection, abscess, infected prosthetic material, resistance or an extracardiac focus.
New weakness, aphasia, seizure, severe headache, reduced consciousness or meningism may represent embolic infarction, haemorrhage, abscess or infected aneurysm. Anticoagulation, thrombolysis and timing of surgery are high-risk multidisciplinary decisions; ordinary acute-ischaemic-stroke assumptions may not apply. Sudden limb pain, absent pulse, abdominal pain, flank pain, splenic tenderness, back pain or visual symptoms can signal systemic embolism or metastatic infection. Right-sided disease may cause recurrent septic pulmonary emboli, pleuritic pain and hypoxaemia.
Fever in a person with a prosthetic valve, prior endocarditis or recent device procedure requires a low threshold for cultures and imaging. S. aureus, fungal infection, prosthetic-valve infection and infection with rapidly destructive organisms merit early expert involvement even before every criterion is fulfilled. Major antimicrobial toxicity is also a red flag: falling renal function, hearing symptoms, cytopenias, hepatitis, severe rash, line sepsis or arrhythmia needs immediate review rather than silent continuation. Apparent improvement after a short antibiotic course does not exclude partially treated endocarditis; relapse of fever or inflammation after therapy requires repeat cultures before more antibiotics when stable.
Indian Clinical Context
Indian practice must account for both rheumatic valve substrates and contemporary healthcare-associated infection. A young adult with rheumatic mitral disease, an older person after valve replacement, a haemodialysis patient and a person with a cardiac device have different organisms, complications and access needs. Previous over-the-counter or empirically dispensed antibiotics can sterilise cultures without treating valve infection. Clinicians should ask non-judgmentally about every tablet and injection, retrieve outside laboratory reports and collect adequate cultures before another dose whenever haemodynamic stability permits.
Microbiology capacity varies. Correct blood volume, separate peripheral venepunctures, prompt transport, incubation and communication with the laboratory may improve yield more than ordering a broad molecular panel. Referral hospitals should not assume that a negative culture from a small sample after antibiotics is equivalent to culture-negative endocarditis. Conversely, advanced serology, PCR, PET/CT and valve-tissue testing should be targeted because availability, validation and cost differ. Preserve excised valve tissue for histopathology, culture and molecular testing under an agreed protocol.
ICMR antimicrobial guidance is a rational national reference but expressly requires local customization because resistance varies between institutions and even departments. Therefore this guide gives prescribing principles rather than a universal Indian empirical cocktail. Cardiac surgery access, transfer time, blood-bank capability and ability to complete prolonged therapy must enter the plan early. Oral health and sterile vascular access are broadly applicable prevention measures. Procedure-related prophylaxis is narrow and should follow an applicable current protocol; indiscriminate prophylaxis will not correct poor dental care or asepsis. Discharge planning must include affordable medicines, line care, laboratory access, transport, a functioning emergency contact and written relapse warnings in a language the patient understands.
NMC Competency Mapping
The NMC CBME 2024 curriculum maps infective endocarditis across disciplines. PA26.7 requires description of its aetiology, pathophysiology, gross and microscopic features, diagnosis and complications. GM1.2 explicitly connects rheumatic fever and rheumatic valvular disease with penicillin prophylaxis and complications including infective endocarditis; GM1.8 includes eliciting features suggestive of endocarditis during a cardiovascular history. Microbiology competencies require recognition of associated organisms, appropriate specimen collection and laboratory interpretation. Pharmacology contributes antimicrobial mechanisms, adverse effects, interactions and stewardship.
An undergraduate learner should construct a pre-test probability from valve or device history, healthcare and injection exposures, fever, heart failure, emboli and persistent bacteraemia. They should obtain blood cultures correctly before antibiotics in a stable patient, understand why multiple sets matter, request transthoracic echocardiography and explain when transoesophageal imaging or repetition is needed. They should use Duke-ISCVID categories as structured evidence, not as permission to ignore a deteriorating patient or a compelling alternative diagnosis.
The learner should connect vegetation with embolism, valve destruction with regurgitation and heart failure, immune phenomena with renal or cutaneous findings, and peri-annular extension with conduction abnormalities. They should describe broad antimicrobial and surgical principles without choosing a definitive regimen or operative timing independently. Competence includes communicating culture timing, avoiding pre-culture antibiotics when safe, escalating red flags and making a usable referral. Reading this guide does not certify transoesophageal echocardiography, antimicrobial prescribing, device extraction, valve surgery or management of neurological complications.
Key Exam Pearls for NEET PG
Vegetations contain platelets, fibrin, microorganisms and inflammatory material. Acute endocarditis is often rapidly destructive; subacute disease may evolve over weeks on an abnormal valve. S. aureus can infect normal valves and commonly causes acute disease. Viridans streptococci classically follow oral sources, enterococci may follow gastrointestinal or genitourinary contexts, and S. gallolyticus bacteraemia should prompt evaluation for colonic pathology according to clinical guidance. HACEK organisms are fastidious Gram-negative causes. Right-sided endocarditis commonly involves the tricuspid valve and can produce septic pulmonary emboli.
Duke-ISCVID diagnosis combines pathological or clinical evidence. Major clinical domains include microbiology and imaging, with surgical evidence added in the 2023 update; minor features include predisposition, fever, vascular and immunological phenomena and microbiological evidence not meeting a major criterion. Three properly collected culture sets before antibiotics and echocardiography are central exam answers, but resuscitation takes priority in shock. A negative transthoracic study does not exclude prosthetic-valve, device-associated or high-suspicion disease; transoesophageal imaging and repeat study may be required.
Janeway lesions are classically painless vascular lesions, while Osler nodes are tender immunological lesions. Roth spots and splinter haemorrhages are not specific. New conduction block suggests peri-annular extension. The three broad reasons for surgery are heart failure, uncontrolled infection and embolic prevention in selected high-risk settings. Antibiotics are organism- and valve-specific and should be narrowed using susceptibility. Prophylaxis is not given for every murmur or every procedure; it is concentrated on highest-risk cardiac conditions and specified dental procedures. Never start anticoagulation solely to prevent septic emboli, and never treat diagnostic criteria as a substitute for clinical judgement.
Frequently Asked Questions
Should antibiotics be started before blood cultures in suspected infective endocarditis?
In a haemodynamically stable patient, obtain multiple adequate blood-culture sets before antibiotics because organism identification directs safer narrow therapy. In severe sepsis, shock or rapidly destructive disease, collect cultures immediately and then start empirical treatment without harmful delay. The exact regimen requires specialist and local-resistance input.
Does a normal transthoracic echocardiogram rule out infective endocarditis?
No. Early infection, prosthetic material, devices, small vegetations and poor acoustic windows reduce sensitivity. If clinical suspicion remains high, transoesophageal echocardiography, repeat imaging and selected CT, nuclear or magnetic-resonance imaging may be needed. Imaging must be integrated with cultures, examination and complications.
Who needs antibiotic prophylaxis before dental procedures?
Current international guidance limits prophylaxis to people with defined cardiac conditions carrying the highest risk of adverse outcomes and dental procedures involving gingival, periapical or oral-mucosal manipulation. Not every native valve lesion qualifies. Oral health and regular dental care remain important for a much broader population.
Why can surgery be required while the patient is still receiving antibiotics?
Antibiotics cannot reliably correct severe valve destruction, drain every peri-annular abscess or eliminate infection on some prosthetic material. Heart failure, uncontrolled infection and selected high embolic-risk situations may require early surgery. Timing is decided by an Endocarditis Team, especially when stroke or intracranial bleeding complicates the case.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic